Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ludivine Zoute is active.

Publication


Featured researches published by Ludivine Zoute.


Journal of Organic Chemistry | 2009

Diethylzinc-Mediated One-Step Stereoselective Synthesis of α-Fluoroacrylates from Aldehydes and Ketones. Two Different Pathways Depending on the Carbonyl Partner

Gérald Lemonnier; Ludivine Zoute; Georges Dupas; Jean-Charles Quirion; Philippe Jubault

A efficient methodology allowing the one-pot stereoselective synthesis of alpha-fluoroacrylates, based on the addition of ethyl dibromofluoroacetate to a carbonyl derivative using diethylzinc as organometallic mediator, is described. Two different pathways have been identified depending on the involved carbonyl partner. In the case of aldehydes, an E2-type mechanism has been identified, whereas ketones go through an E1cb-type mechanism.


Bioorganic & Medicinal Chemistry | 2018

N-Thiazolylamide-based free fatty-acid 2 receptor agonists: Discovery, lead optimization and demonstration of off-target effect in a diabetes model

Hamid R. Hoveyda; Graeme Fraser; Ludivine Zoute; Guillaume Dutheuil; Didier Schils; Cyrille Evangelos Brantis; Alexey Lapin; Julien Parcq; Sandra Guitard; Francois Lenoir; Mohamed El Bousmaqui; Sarah Rorive; Sandrine Hospied; Sébastien Blanc; Jérôme Bernard; Frédéric Ooms; Joanne C. McNelis; Jerrold M. Olefsky

Free fatty acid-2 (FFA2) receptor is a G-protein coupled receptor of interest in the development of therapeutics in metabolic and inflammatory disease areas. The discovery and optimization of an N-thiazolylamide carboxylic acid FFA2 agonist scaffold is described. Dual key objectives were to i) evaluate the potential of this scaffold for lead optimization in particular with respect to safety de-risking physicochemical properties, i.e. lipophilicity and aromatic content, and ii) to demonstrate the utility of selected lead analogues from this scaffold in a pertinent in vivo model such as oral glucose tolerance test (OGTT). As such, a concomitant improvement in bioactivity together with lipophilic ligand efficiency (LLE) and fraction sp3 content (Fsp3) parameters guided these efforts. Compound 10 was advanced into studies in mice on the basis of its optimized profile vs initial lead 1 (ΔLLE = 0.3, ΔFsp3 = 0.24). Although active in OGTT, 10 also displayed similar activity in the FFA2-knockout mice. Given this off-target OGTT effect, we discontinued development of this FFA2 agonist scaffold.


Archive | 2009

Compounds, pharmaceutical composition and methods for use in treating metabolic disorders

Hamid R. Hoveyda; Cyrille Evangelos Brantis; Guillaume Dutheuil; Ludivine Zoute; Didier Schils; Jérôme Bernard


Archive | 2012

Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43)

Hamid Hoveyda; Didier Schils; Ludivine Zoute; Julien Parcq


Archive | 2011

Novel compounds, method for use them and pharmaceutical composition containing them

Hamid Hoveyda; Ludivine Zoute; Francois Lenoir


Archive | 2015

Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases

Hamid Hoveyda; Didier Schils; Ludivine Zoute; Julien Parcq; Jérôme Bernard; Graeme Fraser


Archive | 2010

Compounds, pharmaceutical composition and methods for use in treating gastrointestinal disorders

Hamid Hoveyda; Cyrille Evangelos Brantis; Guillaume Dutheuil; Ludivine Zoute; Didier Schils; Graeme Fraser


Synthesis | 2006

Efficient synthesis of fluoroalkenes via diethylzinc-promoted wittig reaction

Ludivine Zoute; Guillaume Dutheuil; Jean-Charles Quirion; Philippe Jubault; Xavier Pannecoucke


Archive | 2018

Pyrrolidine carboxylic acid derivatives as agonists of G-protein coupled receptor 43 (GPR43), pharmaceutical composition and methods for use in treating metabolic disorders

Hamid Hoveyda; Didier Schils; Ludivine Zoute; Julien Parcq


Archive | 2017

derivados de ácido carboxílico de pirrolidina ou tiazolidina, composição farmacêutica e métodos para uso no tratamento de distúrbios metabólicos como agonistas de receptor 43 acoplado à proteína g (gpr43).

Didier Schils; Hamid Hoveyda; Julien Parcq; Ludivine Zoute

Collaboration


Dive into the Ludivine Zoute's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Guillaume Dutheuil

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jean-Charles Quirion

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Georges Dupas

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Gérald Lemonnier

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Xavier Pannecoucke

Centre national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge